Chimin Health Management Hits Day High with 10.03% Surge in Stock Price

Chimin Health Management Co., Ltd. has experienced a significant uptick in its stock performance, gaining 10.03% on June 29, 2026. The stock reached an intraday high of CNY 7.68, marking a notable moment in its trading activity. This performance stands in contrast to the China Shanghai Composite, which only saw a modest increase of 1.16% on the same day. Despite this daily surge, Chimin Health's longer-term performance metrics reveal a more complex picture. Over the past month, the stock has declined by 12.53%, and year-to-date, it has dropped 15.88%. The company operates within the Pharmaceuticals & Biotechnology sector and has a market capitalization of CNY 4,599 million, categorizing it as a small-cap entity. Financial indicators show that Chimin Health has faced challenges, including a negative return on equity of -23.31% and a debt-to-equity ratio of 0.40. The company has reported a decline in net sales and profits over recent quarters, reflecting ongoing difficulties in its operational performance. As the stock continues to navigate these trends, its recent high may serve as a focal point for market observers.